Company / Shareholders' Equity
BICYCLE THERAPEUTICS PLC Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$610.0M
FY2025
5-year range
$270.8M / $793.1M
FY2021-FY2025
Trend
-23.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 7 years, ranging from $93M in FY2019 to $793M in FY2024.
Based on SEC 10-K filings.
$610M in FY2025 with a 5-year CAGR of +44.9%.
Improved from $371M to $610M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +31.1%
- 5-Year CAGR
- +44.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +44.9%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 23.1% year-over-year.
- Peak shareholders' equity was recorded in FY2024.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $610.0M | -23.1% |
| FY2024 | $793.1M | +113.8% |
| FY2023 | $370.9M | +37.0% |
| FY2022 | $270.8M | -21.8% |
| FY2021 | $346.3M | +262.7% |
| FY2020 | $95.5M | +2.4% |
| FY2019 | $93.2M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026